Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 1999, p. 850-855, Vol. 43, No. 4
Laboratoire et Service d'Infectiologie,
Centre Hospitalier de l'Université Laval, Sainte-Foy
Québec, Canada,1 and
Infectious Disease Division, Massachusetts General
Hospital, Harvard Medical School, Boston,
Massachusetts2
Received 27 August 1998/Returned for modification 14 December
1998/Accepted 30 January 1999
The two groups of chromosomal In a recent study, the chromosomal In order to verify that the mutations previously described increase the
promoter strength and to quantify the effects of these mutations on the
promoters, we determined the relative strengths of the different
versions of the promoters from blaOXY-1
and blaOXY-2 in two different species,
Escherichia coli and K. oxytoca, using a
promoter-probe vector. As OXY-1 and OXY-2 Bacterial strains and plasmids.
The strains and plasmids
used in this study are listed in Table 1.
All K. oxytoca strains used for the cloning of
promoters were previously identified and analyzed for the promoter
sequences and the types (OXY-1 or OXY-2) of their
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Strength and Regulation of the Different Promoters
for Chromosomal
-Lactamases of Klebsiella
oxytoca
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactamases from Klebsiella
oxytoca (OXY-1 and OXY-2) can be overproduced 73- to 223-fold, due to point mutations in the consensus sequences of their promoters. The different versions of promoters from
blaOXY-1 and blaOXY-2 were cloned upstream of the chloramphenicol acetyltransferase (CAT)
gene of pKK232-8, and their relative strengths were determined in
Escherichia coli and in K. oxytoca. The three different mutations in the OXY
-lactamase promoters resulted in a 4- to 31-fold increase in CAT
activity compared to that of the wild-type promoter. The G
T
transversion in the first base of the
10 consensus sequence caused a
greater increase in the promoter strength of the wild-type promoter
than the two other principal mutations (a G-to-A transition of the
fifth base of the
10 consensus sequence and a T-to-A transversion of
the fourth base of the
35 sequence). The strength of the promoter carrying a double mutation (transition in the Pribnow box and the
transversion in the
35 hexamer) was increased 15- to 61-fold in
comparison to that of the wild-type promoter. A change from 17 to 16 bp
between the
35 and
10 consensus sequences resulted in a ninefold
decrease of the promoter strength. The expression of the
blaOXY promoter in E. coli
differs from that in K. oxytoca, particularly for
promoters carrying strong mutations. Furthermore, the
blaOXY promoter appears not to be controlled by
DNA supercoiling or an upstream curved DNA, but it is dependent on the
gene copy number.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-Lactamases catalyze the
hydrolysis of the
-lactam ring of
-lactam antibiotics. Genes that
encode
-lactamases can be found on the bacterial
chromosome or on plasmids (21). Expression of chromosomal
-lactamase is either inducible (most chromosomal
-lactamases) or constitutive (29).
Klebsiella oxytoca is a bacterium that carries a
chromosomally encoded
-lactamase, which is naturally
synthesized constitutively at a low level.
-lactamase
genes of K. oxytoca were divided into two main
groups: blaOXY-1 and
blaOXY-2. Some plasmid-encoded
-lactamases, such as MEN-1 (3) and TOHO-1 (16), are derived from these K. oxytoca
-lactamases. The two
-lactamase genes
blaOXY-1 and blaOXY-2
were found to be very similar (nucleotide identity, 87.3%)
(12). However, it has been demonstrated that OXY-2
-lactamase hydrolyzed
-lactams differently from OXY-1
-lactamases, and within the OXY-1 group, some
differences in the catalytic efficiencies were also observed
(11). Several strains can overproduce
-lactamase 73- to 223-fold (8, 10). This
-lactamase overproduction confers on the bacteria
resistance to penicillins and some extended-spectrum
-lactams,
especially aztreonam. The molecular basis of this overproduction is
point mutations in the promoter consensus sequences of the
-lactamase gene (10). Three types of mutation
were described: a G-to-A transition of the fifth base of the
10
consensus sequence, a G-to-T transversion of the first base of the
same hexamer, and a T-to-A transversion of the fourth base of the
35
sequence (9). Rarely, a double mutation is observed
(9). However, the amounts of
-lactamase in
strains carrying the same promoter can be slightly different (9,
10). This could be explained by the difference in
-lactamase substrate profile (11).
-lactamases
have different catalytic efficiencies, the
blaOXY promoters were cloned upstream of the
cat gene. A 4- to 31-fold increase was observed when the
promoter was carrying one of the previously described mutations. The
influence of several factors involved in constitutive promoter
regulation (supercoiling, upstream promoter DNA sequence, and gene copy
number) was also studied.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactamases (12).
TABLE 1.
Strains and plasmids used in this study
MICs. MICs for K. oxytoca strains of novobiocin were determined by an agar dilution method as previously described (8).
Cloning of the bla promoter in pKK232-8. The 480-bp EcoRI-PstI fragments of pBOF-1 and pBOF-4 (8) were isolated and cut with AluI. The 60-bp EcoRI-AluI fragment was cloned into pBluescript II KS(+) (Stratagene) cut with the EcoRI plus EcoRV enzymes to create pLQ921 and pLQ923, respectively. These clones were recut with BamHI plus HindIII, and the fragments were cloned into pKK232-8 (Pharmacia Canada) cut with BamHI plus HindIII to create pLQ922 and pLQ924, respectively (Table 1) (Fig. 1).
|
Cloning of the bla gene into pBGS18+.
The entire
chromosomal
-lactamase genes of SL781 and SL7811 were
cloned into pBGS18+. The primer containing a BamHI site described above and another, previously described, primer containing an
SmaI site (11) were used. The PCR products from
SL781 and SL7811 cut by BamHI and SmaI were
cloned into pBGS18+ (31) cut by the same enzymes to give
pBF9 and pBF10, respectively (Table 1).
Enzyme assays.
Enzyme activities were assayed in crude
extracts prepared by sonication in 1 mM Tris-HCl (pH 7.6)
(19). Protein concentrations were measured by the Bradford
protein assay (Bio-Rad). Chloramphenicol acetyltransferase (CAT)
activity was determined with the phase-extraction assay previously
described by Seed and Sheen (30). Crude extracts were
diluted in order to have an activity within the linear range of the
assay, i.e., 0.5 to 19% butyrylated chloramphenicol.
-Lactamase activity was determined spectrophotometrically at 25°C by using cephaloridine as the substrate as previously described (20).
Plasmid pLQ943 construction. Plasmid pSC101 (6) was cut by StuI and ligated to eliminate the 1.5-kb region between the two sites. The resulting plasmid, pLQ942, was digested by SphI and EcoRV. The resulting 3.0-kb fragment contained the pSC101 replicon. Plasmid pKK232-8 was digested by AlwNI. The nuclease Bal-31 eliminated about 100 bp of the beginning of RNAII (of the pMB1 replicon). The plasmid was then filled in with the Klenow fragment and cut with NspI. The resulting 3.9-kb fragment containing the bla and cat genes was ligated with the SphI-EcoRV fragment of pSC101 to create the recombinant plasmid pLQ943 (Table 1).
To confirm that the replicon pSC101 was present and that the replicon of pKK232-8 (replicon pMB1) was not functional, two different experiments were performed. First, introduction of a p15A replicon (plasmid pACYC177), which uses a replication mechanism entirely unrelated to those of pMB1 and pSC101, into cells containing the replicon pMB1 (plasmid pBGS18+) or pSC101 (plasmid pSC101) resulted in compatibility between the resident and the incoming plasmids, and this construct was used as a control. If plasmid pLQ943 was introduced into cells containing pBGS18+, the number of transformants was similar to that in the compatibility control and to that in the cells containing the double transformation pSC101-pBGS18+. In contrast, introduction of pLQ943 into cells containing pSC101 resulted in a 10-fold decrease of the efficiency of the transformation. Second, the effect of pLQ943 on the extent of incompatibility expressed by pSC101 or pBGS18+ was further evaluated by an assay that measures the rate of segregation of incompatible plasmids. The pLQ943 plasmid was retained when it was combined with pBGS18+, but it was lost after one subculture when combined with pSC101 (data not shown).Copy number measurement. Plasmid pACYC177 was used as an internal control and introduced into the strains carrying the different plasmid constructions. Plasmid DNA concentrations were determined in unfractionated detergent sodium dodecyl sulfate lysates by using the method of Chiang et al. (5). The ethidium bromide-stained agarose gels were photographed, and the DNA bands were quantitated by scanning the photographs with a Bioimage, Visage 110S (Millipore). The density of the larger band was normalized to that of the smaller band (from pACYC177) according to their molecular weights.
| |
RESULTS |
|---|
|
|
|---|
-Lactamase promoter strength in pKK232-8.
The promoters of
different OXY
-lactamase genes were cloned upstream of
the cat gene of pKK232-8. This plasmid carries a cat gene without a promoter and a
blaTEM-1 gene. The CAT activity is proportional
to the blaOXY promoter strength, and the TEM
-lactamase activity is proportional to the plasmid copy
number (2): determination of the CAT activity to TEM
-lactamase activity ratios was used to avoid effects due
to plasmid copy number. These plasmids were introduced into either
E. coli HB101 or K. oxytoca SL901.
The ratios and the sequences of the promoters are shown in Table
2. The strengths of the wild-type
promoters from the
-lactamase genes
blaOXY-1 and blaOXY-2
(from plasmids pLQ925 and pLQ927, respectively) were similar: less than
a twofold difference was observed. In E. coli, the
G
T transversion in the first base of the
10 consensus sequence
resulted in a 20-fold increase of the promoter strength of plasmid
pLQ925. This increase is greater than that produced by the two other
principal mutations. With the same transversion from the
blaOXY-2 gene only a fivefold increase was
observed. The two other mutations, a transition (G
A at position 5 of
the
10 consensus sequence) and a transversion (T
A at position 4 of
the
35 consensus sequence), had similar effects, resulting in a four-
to ninefold increase over wild-type promoter strength. One promoter
carries both of these mutations (transition in the Pribnow box and
transversion in the
35 hexamer) (plasmid pLQ939). This promoter
resulted in a 15-fold increase in CAT expression in E. coli. Secondary mutations (T
C and G
C at 6 and 4 bp upstream of the
35 consensus sequence, respectively) did not significantly modify the promoter strength either in the wild-type promoter (pLQ926)
or in the strong promoters (pLQ929, pLQ930, pLQ933, and pLQ934).
However, a G
A mutation at 3 bp downstream of the
10 consensus
sequence (plasmid pLQ931) seemed to increase the promoter strength by
about twofold.
|
-lactamase
activity ratio slightly lower than that of the plasmid pLQ925, probably
due to the smaller size of the cloned fragment (the AluI
site used in the cloning is close to the transcription initiation site)
(Table 2) (Fig. 1). The plasmid pLQ924 carried the same 60-bp fragment
harboring the G
T transversion and a one-base deletion located 4 bp
upstream of the
10 consensus sequence from pBOF-4. The change of 17 to 16 bp between the two consensus sequences resulted in a ninefold decrease of the promoter strength relative to that of pLQ932, which
carries only the transversion.
The strength of the tac promoter was determined with two
different plasmids, i.e., plasmid pLQ880, which carries a 90-bp
fragment (19), and pLQ941, which carries a 450-bp fragment.
A significant difference was observed between the activities of the two
plasmids. The CAT activity/TEM
-lactamase activity ratio
of pLQ941 was threefold higher than that of plasmid pLQ880, probably
again due to the larger size of the cloned fragment.
In K. oxytoca SL901, expression of the
wild-type blaOXY-1 and
blaOXY-2 promoters was similar to that in
E. coli: the difference was less than twofold. However,
the ratios of the mutated promoters compared to those of wild type
were much higher than those in E. coli for
blaOXY-1 and blaOXY-2.
This effect was particularly noticeable with the strong mutations, such
as the G
T transversion (position 1, Pribnow box) and the double
mutation of the plasmid pLQ939. With this plasmid, the ratio became
61-fold instead of 15-fold as in E. coli.
When we quantify the strengths of these mutated promoters on the
chromosome by measuring the
-lactamase activity,
the promoter mutations are found to increase the promoter strength
of the wild-type promoter 76- to 223-fold (8-10).
When the ratios of the activities of chromosomally located mutated
promoters to wild-type promoters were compared to those obtained
with the same promoters located on plasmids (Table 2), a sevenfold
lesser difference was observed when the promoters were cloned into a
plasmid. We decided to determine the origin of this difference.
Effect of supercoiling on promoter strength.
In order to study
the effect of supercoiling on the blaOXY
promoter, K. oxytoca SL901 containing the plasmid
pLQ925 carrying a wild-type promoter was grown for 2 h during the
exponential phase in the presence of three different concentrations of
novobiocin (2, 6, and 12 µg/ml, corresponding to 1/15, 1/5, and 1/2.5
of the MIC of novobiocin). Novobiocin inhibits DNA gyrase and reduces supercoiling. However, the CAT and TEM
-lactamase
activities of the cells grown in the presence of novobiocin were
similar to those of the cells grown in the absence of novobiocin (data not shown), suggesting that the bla promoter is not
controlled by supercoiling.
Effect of an upstream DNA sequence on promoter strength.
When
we sequenced the region upstream of the
-lactamase gene,
we found another apparent divergently transcribed gene whose putative
promoter overlapped that of the
-lactamase gene (data not shown). This new gene had similarity with several other genes for which sequences are deposited in the data libraries. These genes, a
dehydrogenase involved in rhizopine catabolism in Rhizobium meliloti and a glucose-fructose oxidoreductase of
Zymomonas mobilis, are both regulated. This finding
suggested that the
-lactamase promoter could be
influenced by the regulation of this upstream gene. In order to
determine if the DNA located upstream of the promoter
influenced blaOXY promoter strength, the
BamHI-HindIII fragment containing the
wild-type bla promoter was truncated 160 bp by using an
EcoRI site present at 18 bp upstream of the
35 consensus
sequence of the blaOXY promoter. The
putative promoter of the divergently transcribed gene was
removed from this new fragment. The activity of this plasmid, pBF11,
was compared to that of pLQ925, which carries the whole 360-bp promoter
fragment. No significant difference between the CAT activity/TEM
-lactamase activity ratios of pBF11 and pLQ925 was
observed (data not shown), indicating that this putative gene does not
affect the expression of
-lactamase.
Effect of gene copy number on promoter strength.
In order to
verify that the observed difference was related to the plasmid copy
number, a plasmid with a copy number lower than that of pKK232-8 was
constructed. In plasmid pLQ943, the replicon of plasmid pSC101
was substituted for the pMB1 replicon of pKK232-8. The relative plasmid
copy number was determined by two methods. First, the plasmid DNA was
extracted and analyzed in agarose gels with pACYC177 used as an
internal control. The gel photograph was then scanned. pKK232-8
showed a copy number of 25 copies per cell either in E. coli or in K. oxytoca, while pLQ943 showed
copy numbers of 10 copies per cell in E. coli and 7 copies per cell in K. oxytoca. Second, the TEM
-lactamase activities produced by both plasmids were
determined. The TEM
-lactamase activity was proportional
to the copy number of the plasmid (2). In E. coli, the quantity of
-lactamase produced by pLQ943
was 3.9-fold lower than that produced by pKK232-8, and in
K. oxytoca, the difference was 4.7-fold. This
confirmed that the plasmid pLQ943 has a copy number about
fourfold lower than that of pKK232-8.
-lactamase activities are increased by 2.7-fold
in E. coli and 2.9-fold in K. oxytoca. As previously mentioned, the TEM
-lactamase activities were decreased fourfold, but the
CAT activities in cells containing pLQ943 were only 1.5-fold lower than
those in cells containing pKK232-8, indicating an increase of the
expression of the promoter as the plasmid copy number decreases. Ratios
between the wild-type promoter and the different mutated promoters
were higher than that obtained for pKK232-8, particularly for the
double mutant: for the plasmid pLQ948, the ratio was 1.7 to 2.1-fold
higher than that for the plasmid derived from pKK232-8.
|
-lactamase gene were cloned into pBGS18+. One clone
carried a wild-type promoter, and the other had the
transversion in the
10 consensus sequence. The OXY
-lactamase activities for these plasmids pBF9
(wild-type) and pBF10 (mutated) were determined as well as those
for the chromosomal
-lactamase. The results are shown in
Table 4. First, between chromosomal
wild-type and mutated
-lactamases, a 243-fold
increase was observed as previously described (10). Second,
between wild-type chromosomal and plasmid-mediated
-lactamase, a 24-fold increase was observed. As
described above, the copy number of plasmids carrying the pMB1 replicon
as pBGS18+ or pKK232-8 is 25 per cell. The 24-fold increase obtained
between the chromosomal and plasmid-mediated locations correlates well
with this result. Third, between plasmid-mediated wild-type and
mutated
-lactamase promoters, we observed only a 24-fold
increase, which correlates well with the 31-fold increase observed for
pLQ932 relative to pLQ925 (Table 2). Fourth, the difference between the
mutated chromosomal
-lactamase and the mutated
plasmid-mediated
-lactamase is only 2.5-fold instead of
the expected 25-fold due to the plasmid copy number of pBGS18+. This
result indicated that the difference observed between the chromosomal
and plasmid-mediated positions is due to the mutated promoter that is
not fully overexpressed when it is on the plasmid.
|
| |
DISCUSSION |
|---|
|
|
|---|
The core promoter is composed of the
35 and
10 hexamers
separated by a spacer. The promoter specifies more-rapid transcription as its elements approach the consensus sequences: the
35 hexamer (TTGACA), the
10 hexamer (TATAAT), and the
spacer between these two sequences (17 bp) (13, 15).
Alterations in the strength of nonconsensus promoters are usually
dependent on both the position of the substitution and the particular
base substituted (17). The three different up-promoter
mutations in the
-lactamase promoters cloned into
pKK232-8 resulted in a 4- to 31-fold increase of the CAT activity
produced by the wild-type (pLQ925) promoter. The G
T transversion
of blaOXY-1 in the first base of the
10
consensus sequence causes a greater increase (20-fold in E. coli and 31-fold in K. oxytoca) in the
promoter strength for the wild-type promoter than the two other
principal mutations. With the same transversion from the
blaOXY-2 gene only a fivefold increase is
observed. It is difficult to explain the difference observed between
the blaOXY-1 and blaOXY-2
promoters carrying the same mutation. However, the base pair just
upstream of the
10 consensus sequence is different: it is a G in
blaOXY-1 and an A in
blaOXY-2 (Table 1). The mutation G
A at this
position was shown to decrease 10-fold the activity of the
trp promoter (25). This single base-pair
difference just upstream of the first base of the
10 hexamer could
perhaps affect the efficiency of the up-promoter mutation in the
adjacent base. The G
A mutation at 3 bp downstream of the
10
consensus sequence (plasmid pLQ931) seemed to increase the
promoter strength about twofold. This mutation is situated between the
10 consensus sequence and the transcriptional start site. The base
pair at this position does not seem to be particularly conserved
according to the study of compiled promoters (14). However,
some up-promoter mutations observed correspond to nonconsensus base
pairs (outside the conserved hexamers) altered to other nonconsensus
base pairs. These data suggest that a hierarchy of base pair preference
could exist at some positions around the hexamers.
The change from 17 to 16 bp in the G
T mutant resulted in a ninefold
decrease of the promoter strength in comparison with the level observed
for the transversion alone. In the promoter compilation study, 92% of
promoters had interregion spacing of 17 bp (14). Maximum
activity was observed at a spacer length of 17 bp (1).
It is interesting that the expression of the cloned blaOXY promoters in E. coli is different from that in K. oxytoca, particularly for promoters carrying strong mutations. This might be explained by the fact that E. coli and K. oxytoca RNA polymerases may read the promoter differently. We can speculate that the nature of the RNA polymerases or their relative concentrations within the two cells could affect the relative values of the promoter strength.
The G
T mutant promoter is sevenfold less overexpressed, in
comparison to the range observed on the chromosome, when the
promoters are cloned into a plasmid. Mechanisms, such as gene
amplification, that could contribute to disproportionate overexpression
of chromosomal
-lactamase production were eliminated in
previous work (10). In addition, our group showed in
previous studies (8, 9) that the spontaneous single-step
mutants obtained in vitro always carry one mutation in the chromosomal
promoter along with a 70- to 200-fold increase of the
-lactamase activity. Finally, we introduced plasmid
pLQ925, which carries the wild-type promoter, into K. oxytoca SL781 and SL7811. SL7811, which is a single-step mutant obtained from the wild-type strain SL781, carries the
transversion in the
10 consensus sequence and overproduces its
chromosomal
-lactamase 223-fold (8). The CAT
activities measured from these two strains were similar (data not
shown), indicating that no factor acting in trans is
involved in this overproduction mechanism. These findings
indicate that the promoter mutation alone is responsible for the
huge increase of the chromosomal blaOXY
production and that the sevenfold difference observed between the
cloned and chromosomally located promoters is due only to the former
being plasmid borne. Different hypotheses could explain this observation.
The production of
-lactamase in K. oxytoca is constitutive (10, 18). Constitutive
promoters are defined as carrying in their sequences all instructions
specifying the transcriptional efficiency of their complexes with RNA
polymerase, in contrast to regulated promoters, which need positive or
negative effectors. During the last decade of research on
transcription, it has been shown that several factors could modify the
activity of a constitutive promoter. One of the most-studied
factors is DNA supercoiling: it influences the expression of many
bacterial genes, enhancing or repressing the activity of some of them
while having no apparent influence on many others (4, 23,
28). Plasmids in general are much more supercoiled than
chromosomal DNA. However, we showed that novobiocin concentrations
approaching the MIC do not modify blaOXY
promoter strength, suggesting that supercoiling is not a factor
involved in expression.
The major determinants of promoter strength are the
35 and
10
hexamers and the conformation of their spacer sequence. However, sequences outside this region but cis to it can
strongly influence activity. A survey of nucleotide sequences of
promoters indicates a clear relationship between promoter strength and
the presence of upstream regions of curved DNA (24, 27). The
deletion of the 160-bp sequence upstream of the
blaOXY promoter does not modify its activity,
indicating that this upstream sequence is not necessary to the
promoter strength. Furthermore, no sequences associated with
curved or bent DNA were found in this region (data not shown). Another
hypothesis is interaction between promoters due to the presence of
another gene transcribed divergently from the
-lactamase gene. The promoters of the two genes might have a certain degree of
overlap. One of the two promoters may be subject to positive regulation
by a factor which represses the activity of the second (and otherwise
constitutive) promoter. Although this situation is frequently observed
in the regulation of metabolic operons (7, 26), an unrelated
gene upstream of the
-lactamase gene could influence the
expression of the
-lactamase promoter. Although we found
an unrelated gene transcribed divergently from the
-lactamase gene, this gene does not seem to
interfere with
-lactamase expression.
The most probable explanation is that promoters that are close to the
consensus sequence may be limited in their activities by promoter
clearance or by competition among strong promoters for the available
RNA polymerase. When we cloned the OXY
-lactamase gene
on a pMB1 replicon plasmid, the mutated promoter was not fully
overexpressed in comparison to the wild-type promoter (Table 4).
Furthermore, when the plasmid copy number was decreased, the
expression of all blaOXY promoters
remained similar, indicating that the strength of this promoter
is dependent on the gene copy number. As it is a strong promoter,
particularly when it is mutated, the transcriptional machinery might
not support a high level of transcription of one kind of mRNA. There is
a limitation in the expression of strong promoters cloned into
multicopy plasmids.
This study confirmed that the mutations in the promoter are responsible
for the overproduction of the chromosomal
-lactamases in
K. oxytoca. Broadening of the spectrum of
resistance caused by an overproduction of chromosomal
-lactamases has previously been described. Bacteria
increase production of chromosomal
-lactamase by several
mechanisms: by promoter mutations or acquisition of insertion sequences
that take over promoter function, as occurs with the constitutive
-lactamase of E. coli; by mutation in a regulator gene, as occurs with the inducible
-lactamases of Enterobacter cloacae and
Pseudomonas species; or by increased gene copy numbers through gene amplification (22).
In addition, we showed that the three different mutations in the OXY
-lactamase promoters resulted in a 4- to 31-fold
increase of the strength of the cloned wild-type promoter. The
G
T transversion in the first base of the
10 consensus sequence
causes a greater increase in the promoter strength of the wild-type
promoter than the two other principal mutations. The expression of the
blaOXY promoter in E. coli is
different from that in K. oxytoca, particularly for
promoters carrying strong mutations. Furthermore, the
blaOXY promoter appears not to be controlled by
supercoiling or an upstream curved DNA, but it is dependent on the gene
copy number.
| |
ACKNOWLEDGMENTS |
|---|
B.F. was supported in part by a fellowship from the Ministère de la Recherche et de l'Espace of France, and A.G. was supported by a fellowship from the Medical Research Council (MRC) of Canada. This work was supported by grant MT-13564 from the MRC of Canada to P.H.R. and in part by grant AI23988 from the National Institutes of Health to D.C.H.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Infectious Disease Division, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114-2696. Phone: (617) 726-3812. Fax: (617) 726-7416. E-mail: fournier{at}helix.mgh.harvard.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aoyama, T.,
M. Takanami,
E. Ohtsuka,
Y. Taniyama,
R. Marumoto,
H. Sato, and M. Ikehara.
1983.
Essential structure of Escherichia coli promoter: effect of spacer length between the two consensus sequences on promoter function.
Nucleic Acids Res.
11:5855-5864 |
| 2. |
Arini, A.,
M. Tuscan, and G. Churchward.
1992.
Replication origin mutations affecting binding of pSC101 plasmid-encoded Rep initiator protein.
J. Bacteriol.
174:456-463 |
| 3. |
Barthélémy, M.,
J. Péduzzi,
H. Bernard,
C. Tancrède, and R. Labia.
1992.
Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum -lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca.
Biochim. Biophys. Acta
1122:15-22[Medline].
|
| 4. | Brahms, J. G., O. Dargouge, S. Brahms, Y. Ohara, and V. Vagner. 1985. Activation and inhibition of transcription by supercoiling. J. Mol. Biol. 181:455-465[Medline]. |
| 5. | Chiang, C.-S., Y.-C. Xu, and H. Bremer. 1991. Role of DnaA protein during replication of plasmid pBR322 in Escherichia coli. Mol. Gen. Genet. 225:435-442[Medline]. |
| 6. |
Cohen, S. N., and A. C. Y. Chang.
1973.
Recircularization and autonomous replication of a sheared R-factor DNA segment in Escherichia coli transformants.
Proc. Natl. Acad. Sci. USA
70:1293-1297 |
| 7. | de Lorenzo, V., M. Herrero, F. Giovannini, and J. B. Neilands. 1988. Fur (ferric uptake regulation) protein and CAP (catabolite activator protein) modulate transcription of fur gene in Escherichia coli. Eur. J. Biochem. 173:537-546[Medline]. |
| 8. |
Fournier, B.,
G. Arlet,
P. H. Lagrange, and A. Philippon.
1994.
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded -lactamase.
FEMS Microbiol. Lett.
116:31-36[Medline].
|
| 9. |
Fournier, B.,
P. H. Lagrange, and A. Philippon.
1996.
-Lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca.
Antimicrob. Agents Chemother.
40:460-463[Abstract].
|
| 10. |
Fournier, B.,
C. Y. Lu,
P. H. Lagrange,
R. Krishnamoorthy, and A. Philippon.
1995.
Point mutation in the Pribnow box, the molecular basis of -lactamase overproduction in Klebsiella oxytoca.
Antimicrob. Agents Chemother.
39:1365-1368[Abstract].
|
| 11. |
Fournier, B., and P. H. Roy.
1997.
Variability of chromosomally encoded -lactamases from Klebsiella oxytoca.
Antimicrob. Agents Chemother.
41:1641-1648[Abstract].
|
| 12. |
Fournier, B.,
P. H. Roy,
P. H. Lagrange, and A. Philippon.
1996.
Chromosomal -lactamase genes of Klebsiella oxytoca are divided into two main groups: blaOXY-1 and blaOXY-2.
Antimicrob. Agents Chemother.
40:454-459[Abstract].
|
| 13. |
Gralla, J. D.
1990.
Promoter recognition and mRNA initiation by Escherichia coli E 70.
Methods Enzymol.
185:37-54[Medline].
|
| 14. |
Harley, C. B., and R. P. Reynolds.
1987.
Analysis of Escherichia coli promoter sequences.
Nucleic Acids Res.
15:2343-2361 |
| 15. |
Hawley, D. K., and W. R. McClure.
1983.
Compilation and analysis of Escherichia coli promoter DNA sequences.
Nucleic Acids Res.
11:2237-2255 |
| 16. |
Ishii, Y.,
A. Ohno,
H. Taguchi,
S. Imajo,
M. Ishiguro, and H. Matsuzawa.
1995.
Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A -lactamase isolated from Escherichia coli.
Antimicrob. Agents Chemother.
39:2269-2275[Abstract].
|
| 17. |
Kobayashi, M.,
K. Nagata, and A. Ishihama.
1990.
Promoter selectivity of Escherichia coli RNA polymerase: effect of base substitutions in the promoter 35 region on promoter strength.
Nucleic Acids Res.
18:7367-7372 |
| 18. | Labia, R., A. Morand, M. Guionie, M. Heitz, and J. S. Pitton. 1986. Bêta-lactamases de Klebsiella oxytoca: étude de leur action sur les céphalosporines de troisième génération. Pathol. Biol. 34:611-615[Medline]. |
| 19. | Lévesque, C., S. Brassard, J. Lapointe, and P. H. Roy. 1994. Diversity and relative strength of tandem promoters for antibiotic-resistance genes of several integrons. Gene 142:49-54[Medline]. |
| 20. | Lupski, J. R., A. A. Ruiz, and G. N. Godson. 1984. Promotion, termination, and antitermination in the rpsU-dnaG-rpoD macromolecular synthesis operon of Escherichia coli K-12. Mol. Gen. Genet. 195:391-401[Medline]. |
| 21. |
Matthew, M.,
R. W. Hedges, and J. T. Smith.
1979.
Types of -lactamase determined by plasmids in gram-negative bacteria.
J. Bacteriol.
138:657-662 |
| 22. |
Medeiros, A. A.
1997.
Evolution and dissemination of -lactamases accelerated by generations of -lactam antibiotics.
Clin. Infect. Dis.
24:S19-S45.
|
| 23. | Meiklejohn, A. L., and J. D. Gralla. 1989. Activation at the lac promoter and its variants. Synergistic effects of catabolite activator protein and supercoiling in vitro. J. Mol. Biol. 207:661-673[Medline]. |
| 24. |
Ohyama, T.,
M. Nagumo,
Y. Hirota, and S. Sakuma.
1992.
Alteration of the curved helical structure located in the upstream region of the -lactamase promoter of plasmid pUC19 and its effect on transcription.
Nucleic Acids Res.
20:1617-1622 |
| 25. | Oppenheim, D. S., G. N. Bennett, and C. Yanofsky. 1980. Escherichia coli RNA polymerase and trp repressor interaction with the promoter-operator region of the tryptophan operon of Salmonella typhimurium. J. Mol. Biol. 144:133-142[Medline]. |
| 26. | Pagel, J. M., J. W. Winkelman, C. W. Adams, and G. W. Hatfield. 1992. DNA topology-mediated regulation of transcription initiation from tandem promoters of the ilvGMEDA operon of Escherichia coli. J. Mol. Biol. 224:919-935[Medline]. |
| 27. |
Pérez-Martin, J.,
F. Rojo, and V. de Lorenzo.
1994.
Promoters responsive to DNA bending: a common theme in prokaryotic gene expression.
Microbiol. Rev.
58:268-290 |
| 28. | Pruss, G. J., and K. Drlica. 1989. DNA supercoiling and prokaryotic transcription. Cell 56:521-523[Medline]. |
| 29. |
Sanders, C. C.
1984.
Inducible -lactamase and non-hydrolytic resistance mechanisms.
J. Antimicrob. Chemother.
13:1-3 |
| 30. | Seed, B., and J.-Y. Sheen. 1988. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67:271-277[Medline]. |
| 31. | Spratt, B. G., P. J. Hedge, S. T. Heesen, A. Edelman, and J. K. Broome-Smith. 1986. Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene 41:337-342[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |